Skip to main content

Table 1 Basic clinical and biochemical characteristics of participants

From: ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population

Variables

Hyperuricemia

n = 151

Control

n = 1055

p-value

sUA (μmmol/L)

441.74 ± 53.53

290.31 ± 60.81

Age

77.01 ± 6.90

76.59 ± 6.32

0.66

Male (n, %)

78 (51.7)

621 (58.9)

0.095

TG (mmol/L)

2.07 ± 1.26

1.43 ± 0.84

8.10 × 10−14

LDL (mmol/L)

3.47 ± 0.78

3.22 ± 0.81

0.001

HDL(mmol/L)

1.24 ± 0.30

1.35 ± 0.32

2.22 × 10− 5

FBG (mmol/L)

6.01 ± 1.50

6.05 ± 1.88

0.31

Serum creatinine (μmol/L)

72.25 ± 12.24

68.83 ± 13.19

0.003

BMI (kg/m2)

26.85 ± 2.34

24.14 ± 2.98

1.01 × 10− 26

Current drinking (%)

30 (19.9)

248 (23.5)

0.35

Current smoking (%)

34 (22.5)

255 (24.2)

0.68

Office SBP (mmHg)

129.34 ± 15.65

127.71 ± 11.61

0.84

Office DBP (mmHg)

78.54 ± 8.66

79.20 ± 11.69

0.25

Hypertension (%)

72 (47.7)

409 (38.8)

0.041

Hypertension treatment

48 (31.8)

198 (18.8)

4.90 × 10−5

Diuretic (%)

6 (4.0)

42 (4.0)

0.99

Diabetes (%)

30 (19.9)

192 (18.2)

0.65